NEW YORK, NY / ACCESSWIRE / December 18, 2024 / If you suffered a loss on your Aehr Test Systems, Inc. (NASDAQ:AEHR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / December 18, 2024 / If you suffered a loss on your Aehr Test Systems, Inc. (NASDAQ:AEHR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / December 18, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Aehr Test Systems, Inc. ("Aehr" or "the Company") (NASDAQ:AEHR) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Aehr securities between January 9, 2024 and March 24, 2024, both dates inclusive (the "Class Period").
Aehr Test Systems excels in wafer-level testing, crucial for SiC, GaN, and AI chips, driving high-margin recurring revenue from consumables like WaferPacks. The company is poised for significant growth with expanding markets in EVs, alternative energy, data centers, and AI, supported by strong market drivers. Financially robust with $40.8M cash, zero debt, and increasing gross margins, Aehr is well-positioned for future expansion and customer acquisition.
NEW YORK, NY / ACCESSWIRE / December 17, 2024 / If you suffered a loss on your Aehr Test Systems, Inc. (NASDAQ:AEHR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / December 17, 2024 / If you suffered a loss on your Aehr Test Systems, Inc. (NASDAQ:AEHR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / December 17, 2024 / If you suffered a loss on your Aehr Test Systems, Inc. (NASDAQ:AEHR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
LOS ANGELES, CA / ACCESSWIRE / December 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Aehr Test Systems, Inc. ("Aehr" or "the Company") (NASDAQ:AEHR) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company 's securities between January 9, 2024 and March 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 3, 2025.
NEW YORK, NY / ACCESSWIRE / December 17, 2024 / If you suffered a loss on your Aehr Test Systems, Inc. (NASDAQ:AEHR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / December 17, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Aehr Test Systems, Inc. ("Aehr" or the "Company") (NASDAQ:AEHR) and certain officers. The class action, filed in the United States District Court for the Northern District of California, and docketed under 24-cv-08683, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Aehr securities between January 9, 2024 and March 24, 2024, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
NEW YORK, NY / ACCESSWIRE / December 17, 2024 / If you suffered a loss on your Aehr Test Systems, Inc. (NASDAQ:AEHR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / December 17, 2024 / If you suffered a loss on your Aehr Test Systems, Inc. (NASDAQ:AEHR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.